QBFM
INSY

QS Batterymarch Financial Management’s Insys Therapeutics, Inc. INSY Stock Holding History

QS Batterymarch Financial Management’s Portfolio INSY Stock Details INSY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		$3.97M Sell
204,736
-21,800
-10% -$342K 0.11% 288
2014
Q2 		$3.54M Buy
226,536
+52,164
+30% +$843K 0.09% 346
2014
Q1 		$3.63M Buy
174,372
+14,472
+9% +$287K 0.07% 368
2013
Q4 		$2.06M Buy
159,900
+5,400
+3% +$74.9K 0.04% 477
2013
Q3 		$1.8M Buy
+154,500
New +$1.27M 0.04% 509

Other funds holding INSY

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ECP
Empyrean Capital Partners Los Angeles, California $3.07B AUM 34.24% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BTP
Bloom Tree Partners New York $215M AUM 17.45% 1-Year Est. Return

QS Batterymarch Financial Management's INSY Position: Q3 2014 in Review

QS Batterymarch Financial Management reduced its Insys Therapeutics, Inc. (INSY) stake by 9.6% in Q3 2014, selling an estimated $342K and leaving 204,736 shares worth $3.97M. The position accounts for 0.11% of the portfolio, ranked #288.

QS Batterymarch Financial Management first reported a position in INSY in Q3 2013 and has held it in 5 quarters since. 111 funds tracked by Wall St. Rank hold INSY as of Q3 2014.

  • QS Batterymarch Financial Management held 204,736 shares of Insys Therapeutics, Inc. worth $3.97M as of Q3 2014.
  • QS Batterymarch Financial Management sold 21,800 Insys Therapeutics, Inc. shares in Q3 2014, an estimated $342K.
  • Insys Therapeutics, Inc. made up 0.11% of QS Batterymarch Financial Management's portfolio in Q3 2014, its #288 holding.
  • QS Batterymarch Financial Management first reported a position in Insys Therapeutics, Inc. in Q3 2013 and has held it in 5 quarters since.
  • 111 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q3 2014.

Based on QS Batterymarch Financial Management's 13F filing for Q3 2014, filed 14 Nov 2014.